{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:27:59Z","timestamp":1783103279985,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clnesp.2024.11.010","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:23:38Z","timestamp":1731691418000},"page":"519-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Continuous glucose monitoring (CGM) for effective glucose control in a pregnant woman living with type IIIa glycogenosis. A case report"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-8962","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Galibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line Dupy","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Attalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Avignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clnesp.2024.11.010_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymgme.2017.08.010","article-title":"Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa","volume":"122","author":"Decostre","year":"2017","journal-title":"Mol Genet Metabol"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.010_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/geno.1996.0611","article-title":"Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5\u2032 flanking region","volume":"38","author":"Bao","year":"1996","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.010_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1566524024605752","article-title":"Molecular characterization of glycogen storage disease type III","volume":"2","author":"Shen","year":"2002","journal-title":"Curr Mol Med"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.010_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410190313","article-title":"Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis","volume":"19","author":"Ugawa","year":"1986","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.clnesp.2024.11.010_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.clnesp.2024.11.010_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10545-014-9756-x","article-title":"Dietary management in glycogen storage disease type III: what is the evidence?","volume":"38","author":"Derks","year":"2015","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.clnesp.2024.11.010_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.clnesp.2024.11.010_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1464-5491.2000.00378.x","article-title":"Diabetes mellitus secondary to glycogen storage disease type III","volume":"17","author":"Oki","year":"2000","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.010_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2265.1995.tb02686.x","article-title":"The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism","volume":"42","author":"Lee","year":"1995","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.010_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10545-011-9384-7","article-title":"Pregnancy and its management in women with GSD type III - a single centre experience","volume":"35","author":"Ramachandran","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"12","key":"10.1016\/j.clnesp.2024.11.010_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/dia.2022.0152","article-title":"Lower glycated hemoglobin with real-time continuous glucose monitoring than with intermittently scanned continuous glucose monitoring after 1 Year: the CORRIDA LIFE study","volume":"24","author":"Radovnick\u00e1","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"issue":"12","key":"10.1016\/j.clnesp.2024.11.010_bib12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.010_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/dia.2018.0359","article-title":"Real-world hypoglycemia avoidance with a continuous glucose monitoring system's predictive low glucose alert","volume":"21","author":"Puhr","year":"2019","journal-title":"Diabetes Technol Therapeut"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.010_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-011-9335-3","article-title":"The use of continuous glucose monitoring in the practical management of glycogen storage disorders","volume":"34","author":"White","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"S2","key":"10.1016\/j.clnesp.2024.11.010_bib15","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1002\/dmrr.518","article-title":"Continuous glucose monitoring in conditions other than diabetes","volume":"20","author":"Maran","year":"2004","journal-title":"Diabetes Metabol Res Rev"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.010_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ymgme.2019.02.008","article-title":"Glycemic control and complications in glycogen storage disease type I: results from the Swiss registry","volume":"126","author":"Kaiser","year":"2019","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.clnesp.2024.11.010_bib17","article-title":"Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia","volume":"2013","author":"Korljan Jelaska","year":"2013","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.010_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/jimd.12383","article-title":"A\u00a0retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: recommended outcome parameters for glucose management","volume":"44","author":"Peeks","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.010_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10545-018-0200-5","article-title":"Role of continuous glucose monitoring in the management of glycogen storage disorders","volume":"41","author":"Herbert","year":"2018","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.010_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10545-018-0167-2","article-title":"A\u00a0preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring","volume":"41","author":"Hoogeveen","year":"2018","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.010_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.arcped.2003.12.027","article-title":"Syst\u00e8me de mesure du glucose en continu: applicatoin \u00e0 la prise en charge des glycog\u00e9noses [Continuous glucose monitoring in children with glycogen storage diseases]","volume":"11","author":"Mallet","year":"2004","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.clnesp.2024.11.010_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1178348","article-title":"Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature","volume":"10","author":"Massimino","year":"2023","journal-title":"Front Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.010_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jmd2.12282","article-title":"Glycogen storage disease type IIIa in pregnant women: a guide to management","volume":"63","author":"Beneru","year":"2022","journal-title":"JIMD Rep"},{"issue":"Supplement 1","key":"10.1016\/j.clnesp.2024.11.010_bib24","article-title":"Continuous glucose monitoring for primary care patients with diabetes: barriers, facilitators, amp; resources to support access","volume":"20","author":"Warman","year":"2022","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.clnesp.2024.11.010_bib25","series-title":"Glycog\u00e9nose de Type III (GSD III pour Glycogen Storage Disease Type III)","year":"2021"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.010_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/dia.2023.0034","article-title":"Reduced acute diabetes events after FreeStyle Libre system initiation in people 65 Years or older with type 2 diabetes on intensive insulin therapy in France","volume":"25","author":"Guerci","year":"2023","journal-title":"Diabetes Technol Therapeut"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.010_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0031-1275516","article-title":"The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes","volume":"29","author":"Thorn","year":"2011","journal-title":"Semin Reprod Med"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:45:15Z","timestamp":1733143515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724015195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S2405457724015195"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.010","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring (CGM) for effective glucose control in a pregnant woman living with type IIIa glycogenosis. A case report","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}